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1019-114 Assessment  of  Ar rhythmogen ic  Potent ia l  in Brugada 
Syndrome: Comparleon Between Two Conf igurat ions  of  
ST Segment Elevation 
Mitsuaki Takami, Takanori Ikeda, Ayaka Kawase, Kenta Kumagai, Tsuyoshi Sakai, Naoki 
Tezuka, Takeshi Nakee, Yoshihise Enjoji, Kaoru Sugi, Tetsu Yamaguchi, Thired 
Department of Internal Medicine Toho University Ohashi Hospital, Tokyo, Japan. 
Background: Two ST-segment configurations (i.e., coved and saddle-back shape) have 
been dascdbed in Brugada-type electrocardiograms (ECGs), but it is controversial which 
one would have stronger arrhtyhmogenic potential. On the other hand, we recently pro- 
posed that conduction disturbance per se is arrhythmogenic in Brugada syndrome. The 
aim of this study was to examine which configuration is highly associated with life-threat- 
ening arrhythmic events and suggests having a stronger conduction disturbance. 
Methods: Consecutive 46 patients (48 ±15 years, 42 men) with Brugada-type ECG, 
undergoing signal-averaged ECG (SAECG), were enrolled. Marked ST-segment eleva- 
tion (>0.1 mV) of either the coved (n=25: group A) or saddle-beck type (n=21: group B) in 
the right chest leads was seen in all patients. No patients had structural heart disease. 
The incidence of history of life-threatening events defined as syncope and aborted sud- 
den death and the value of SAECG were compared between two groups. In this study, 
late potentials (LP) were considered as positive when two criteria (RMS40 <20 IIV and 
LAS40 >38 ms) were met. 
Results: Life-threatening events: A total of 24 patients had a history of life-threatening 
events. The incidence of life-threstening events was 17 patients (68%) in group A and 7 
patients (33%) in group B (P=0.02). SAECG: Although f-QRS duration did not differ 
between two groups (117.0¢12.5 ms vs. 111.0±10.2 ms), RMS40 and LAS40 of group A 
were significantly lower and longer, respectively than those of group B (RMS40:13.4±6.8 
I~V vs. 27.7=12.0 pV; P<0.C001, and LAS40:45.7±9.7 ms vs. 30.9±7.0 ms; P<0.0001). 
The determination of LP in group A was significantly greater than that in group B (22 
patients (88%) vs. 4 patients (19%); P<0.0001). 
Conclusion: Life-thraatening events were highly observed in patients with coved type 
ST-segment elevation. Moreover these patients have stronger conduction disturbances 
compared to patients with saddle-back type ST-segment elevation. When assessing risk 
for sudden death in patients with Brugada-type ECG, the configuration of ST-segment 
elevation should be taken into consideration. 
1019-115 Left Atrial Dimension Is Associated With Atrial 
F ibr i l la t ion Recurrence: Four-Year Echo Follow-Up Data 
RaUka Seth, Martin S. Green, Chades R. Kerr, Stuart J. Connolly, George J. Klein, 
Robert S. Sheldon, Marie Talajic, Xiaohua Wang, Paul Dorian, Karin Humphries, 
University of Ottawa Heart Institute, Ottawa, Ontario, Canada. 
The Canadian Registry of Atrial Fibrillation (CARAF) enrolled subjects with atrial fibrilla- 
tion (AF) at the first ECG-confirmed diagnosis. We have previously found a relationship 
between LA dimension (LA dim) and recurrence of AF at 2 years. 899 patients with newly 
diagnosed non-surgical AF were enrolled beginning in 1990 from 6 Canadian centers. 
Baseline and 4 year (Y4) echocardiographic data were available on 403 patients. Partici- 
pants were followed at 3 months, and then annually for AF status. Patients were classi- 
fied at 4 years as: no recurrent AF (No AF, n=137) or recurrent AF (RAF, n=266) based 
on clinical symptoms or ECG documentation. The RAF patients were subdivided into 
paroxysmal AF (PAF, n=123), chronic AF (CAF, n=140) and other (n=3). 
The mean age was 63+/-12 years, 37% were women, history of M115%, mitral valve dis- 
ease 12%, hypertension 39%, diabetes 7%, CHF 14%, left ventricular fractional shorten- 
ing 36%+/-10%. For the 403 patients, the mean LA dim was 39.92+/-7.89 mm at 
baseline, and increased to 41.18+/-8.60 mm at 4 years. Compared to the No AF group, 
the RAF group had a larger LA dim at baseline (p<0.001) and a trend toward a larger 
increase in LA dim over 4 years (p=0.053). Those who had developed CAF by 4 years 
had a larger LA dim at baseline and a larger increase in LA dim over 4 years when com- 
pared to PAF (p<0.001). See Table. 
Conclusions: Larger baseline LA dim is associated with AF recurrence. Patients who 
progressed to CAF had the largest baseline LA dim and the greatest increase in LA size 
over 4 years. 
Mean LA dim (ram) in AF groups 
AF group Baseline (SD) Year 4 (SD) 
All N=403 39.92 (7.89) 41.18 (8.60)* 
NoAF N=137 37,59 (7.41) 37.96 (7.91) 
RAF N=266 41.12 (7.87) 42.84 (8.49)* 
PAF N=123 39.06 (7.35) 39.00 (7.50) 
CAF N=140 43.13 (7.73) 46.30 (7.78)* 
*p<0.0Ol 
1019-116 Ef fects  o f  C lass  III Drugs on Prophylaxis of  Atr ia l  
F ibr i l la t ion Af ter  Card ivere ion  in High Risk Patients for 
Recurrence Predicted by P Wave Signal-Averaged ECG 
Koichi Mizumaki. Akira Fujiki, Hidehiko Nagasawa, Masao Sakabe, Kunihiro Nishida, 
Masafaka Sugao, Hiroshi Inoue, The 2rid Department of Internal Medicine, Toyama 
Medical and Pharmaceutical University, Toyama, Japan. 
Though P wave signal-averaged ECG (P-SAE) may predict recurrence of atrial fibrillation 
(AF) after cardioversion (CV), prophylactic therapy in high risk patients (pts) for AF recur- 
rence remains to be established. So, this study aimed to evaluate prophylactic effects of 
class III antiarrhythmic drugs in high risk pts for AF recurrence after CV predicted by P- 
SAE. Methods: P-SAE was recorded within 24 hours after successful CV of chronic or 
paroxysmal AI~ Abnormal P-SAE was defined as the filtered P wave duration(FPD)>137 
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msec and roof-mean-square voltage for the last 20 ms(LP20)<2.61W, which had a sensi- 
tivity of 89% and a specificity of 65% for the prediction of AF recurrence after CV 
obtained from 40 pts. Another 30 pts with abnormal P-SAE were treated with class I 
drugs (group I, n=17) or class III (amiodarone:7,dl-sofalol:6) drugs (group III, n=13) after 
CV of AF and we prospectively evaluated recurrence of AF during 6 months. Results: 
Class I drugs elongated FPD (151_+ 23 vs 166±19 msec, p<0.05) and decreased LP20 
(2.3_+ 0.4 vs 1.9±0.5pV, p<0.O5). However, class Ill drugs did not alter significantly both 
FPD(171_+ 32 vs 176±34 msec) and LP2O (1.7+_ 0.7 vs 1.9-+0.6pV). The recurrence rate 
of AF was significantly lower (p<0.05) in group Ill (5/13,38%) than in group I (13/17,76%). 
Conclusione: In high risk pts for AF recurrence after CV predicted by P-SAE, class Ill 
drugs did not worsen P-SAE variables, whereas class I drugs did. Thus, class III drugs 
were more effective than class I drugs to prevent AF recurrence in these pts. 
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1019-117 Exerc i se  is Super io r  to  Pacing for T Wave Alternans 
Measurement 
Eric J. Rashba, Ahmed Osman, Karen MacMurdy, Samantha Sarang, Stephen R. 
Shorofsky, Michael R. Gold, University of Maryland, Baltimore, Maryland. 
Background: T wave altemans (TWA) is a heart rste-dapecdent measure of vulnerabil- 
ity to ventdcular arrbythmias. Atrial pacing and exercise are both used as provocative 
stimuli to elicit TWA. However, the prognostic value of these two testing methods has not 
been compared. 
Methods: This was a prospective study of 251 patients with coronary artery disease and 
EF _< 40% who were referred for electrophysiologic studies. TWA testing was performed 
with atrial pacing (n=178) or exercise (n=f43) in the absence of anti-arrhythmic drugs or 
beta-blockers; 70 of these patients had testing with both sodalities. The endpoint was 
the combined incidence of sustained ventricular arrhythmia, appropriate defibrillator ther- 
apy or death. 
Results: The cohort had a mean age of 65+10 years, mean ejection fraction of 27_+8 % 
and 89% had symptomatic heart failure. The mean duration of follow-up was 499~395 
days. There were no significant differences in baseline characteristics or treatment 
between the atrial pacing and exercise groups. Cox survivat analysis in subjects with 
determinate results revealed that exercise TWA was an independent predictor of arrhyth- 
sic events (HR 2.5, 95% CI 1.2 - 5.3, p = 0.02). In contrast, pacing TWA did not predict 
outcome events (HR=1.1,95% CI 0.6 - 1.9, p = 0.8). in the subgroup that had both tests 
performed, pacing TWA yielded more positive tests (73% vs 47%) and fewer indetermi- 
nate results (7% vs 27%, p = 0.02); the concordance between pacing and exercise TWA 
results was only 56%. 
Conclusion: Exercise TWA is useful for risk stratification of patients with ischemic cardi- 
omyopathy. Pacing TWA does not have prognostic value in this population. 
1019-118 Abnormal QT Prolongation and Peychotroplc Drug 
Therapy in Psychiatric Patients: S ign i f i cance  o f  
Bradycardia-Dependent QT Prolongation 
Tsuneaki Sadanaga. Fumiko Sadanaga, Hiroshi Yao, Kyushu Universi~ Fukuoka, 
Japan. 
Background: Sudden unexplained death in psychiatric patients might be associated with 
drug-induced arrhythmias. Since many psychotropic drugs have electrophysiological prop- 
erties similar to class I antiarrhythmic drugs, they might lengthen QT interval and cause tor- 
sabes de pointes, Methods: Electrocardiograms (ECG) were obtained in 409 psychiatric 
patients (229 men, 180 women) receiving psychotropic drugs at the Hizen National Hospi- 
tal. QTc was calculated by the Bazett's formula. In order to elucidate the heart rate depen- 
dence of QT prolongation, QT intervals and the preceding R-R intervals (50-100 beats) 
were measured at various heart rates (50-100/min) by 24-hour Holter ECG (CM5 lead) in 
77 patients. We estimated the QT intervals at the heart rates of 80 and 50/min (QT80, 
QT50) by the regression curve (square root of preceding R-R intervals vs. QT intervals). 
Results: Mean QTc interval (longest in 12 ECG leads) was prolonged to 444=32 ms (men, 
437±32, women, 453:~.9 ms, mean heart rate 82±15/min). QTc interval >460 ms was 
observed in 92 (22%) patients (16% in men and 31% in women). QTc interval >500 ms was 
observed in 19 (5%) patients (3% in men and 7% in women). Mean QT80 and QT5O were 
385±27 and 466±42 ms, which were significantly longer than those in healthy reference 
group (QT80 and QT50, 370±15 and 440±20 ms, n=65). QT80 > 400 ms (mean+2SD of 
the reference group) was observed in 16 (21%) patients. In the remaining 61 patients in 
whom QT80 < 400ms, bradycardia-dependent QT prolongation was prominent and QT50 
exceeded 480 ms (meen+2SD) in 12 patients, Accordingly, QT50 > 480 ms was observed 
in 28 (36%) patients. Therefore, we need to pay additional attention to the bradycardia- 
dependent QT prolongation even when the QT interval was not prolonged at usual heart 
rates (around 80/min). Since torsedes de pointas is prone to occur at slower heart rates, 
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QT50 could be the better marker of arrhythmogenic risk. Conclusions: A high incidence of 
QT prolongation was observed in psychiatric patients receiving psychotropic drugs and 24- 
hr Holter ECG was useful in evaluating bradycardia-dependent QT prolongation. 
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1041-103 Induction of Cardiac Nerve Sprouting and Sympathetic 
Hyperinnervation by Subthreshold Electrical 
Stimulation of the Left Stellate Ganglion in Dogs 
Moshe Swissa, Sheogmei Zhou, Che-Ming Chang, Angela C. Lai, Adam Cates, Michael 
C. Fishbein, Hrayr S. Karaguezian, Peng-Sheng Chan, Lan S. Chen, Cedars-Sinai 
Medical Center, Los Angeles, California, Children's Hospital and USC Keck School of 
Medicine, Los Angeles, California. 
Background: Subthreshold electrical stimulation in the brain can induce nerve sprouting 
and the kindling model of epilepsy. Whether or not subthreshold electrical stimulation can 
induce cardiac nerve sprouting is unclear. 
Methods: Six dogs were used in the study. The chest was opened from the left 4 th inter- 
costals space, An active fixation pacemaker lead was screwed into the left stellate gan- 
glion (LSG). The lead was connected to a Medtronic Itrel neurostimulator (N-=3) or a 
modified Guidant Discovery pacemaker (N=3) to give rapid stimulation at 20 Hz (0.45 ms 
pulse width) and 5 Hz (1.9 ms pulse width), respectively. We first determined the stimula- 
tion threshold (the lowest voltage output hat produced an abrupt increase of heart rate of 
> 20% from the baseline). The pacemaker output was then programmed to 25% of the 
stimulation threshold for continuous ubthreshold electrical stimulation for 41 
days. The atrial and ventricular tissues were than harvested and stained for nerve mark- 
ers tyrosine hydroxylase (TH), synaptophysin (SYN) and growth-associated protein 43 
(GAP43) by immunocytochemical techniques. Tissues from 6 healthy dogs were used as 
controls. 
Results: The densities (p.mm 2 per mm 2 ) of nerves that stained for TH, SYN and GAP43 
were significantly (P<0.01) higher in dogs with LSG subthreshold electrical stimulation 
compared to matched controls (1657+ 614, 6518± 6060, 4482± 1955 versus 635+_339, 
263+340, 359+~?.96 for left ventricle; 2343:1:1415, 2186+791,2579~1113 versus 502+~68, 
82±2.6, 434+069 for right ventricle; 12334±11128, 11270-±7245, 15300~6473 versus 
1082+1171, 631_+605, 170+-267 for left atrium and 16116±12553, 
20040~10730,26388±11012 versus 2017+1349, 423+358, 650-~1112 for right atrium, 
respectively). The nerve sprouting magnitude was significantly higher in the atrium com- 
pared to the ventricles (P<O.02). Furthermore, the heart weight of LSG group was 
20~14% greater than of the control dogs (P<0.02). 
Conclusions: LSG subthreshold electrical stimulation induces cardiac hypertrophy and 
sympathetic nerve sprouting. These effects are more prominent in the atdum than the 
ventricles. 
1041-104 Catheter Stimulation of Cardiac Parasympathetic 
Nerves in Man: A Novel Technique 
Karl Mischke. Patrick Schauerte, Christian Knackstedt, Markus Zarse, Anil Sinha, 
Thomas Schimpf, Christoph Stallbrink, Peter Hanrath, Rheinisch-Westf&lische 
Technische Hochschule, Aachen, Germany. 
Background: Cardiac parasympathic nerves run alongside the superior vena ceva (SVC) 
and accumulate picardially adjacent to the coronary sinus (CS) orifice. In animals trans- 
vascular catheter stimulation of these nerves results in a negative chronotropic and dro- 
motropic effect without negative inotropy. The present study reports on the first 
experience with transvascular human parasympathetic nerve stimulation (PS) in the SVC 
and CS. 
Methods: During electrophysiologic studies of 23 patients PS was performed in the SVC 
(n=13) or in the proximal CS (n=10). A deflectable multipolar electrode catheter was posi- 
tioned in the SVC just above the atrial junction or into the proximal CS. PS in the SVC 
was performed with a frequency of 20 Hz and stimulation voltages of 10, 20 and 30V dur- 
ing sinus rhythm and during incremental right atrial pacing with a nerve stimulation volt- 
age of 30V. During PS in the proximal CS, atrial myocardial tissue stimulation by high 
frequency nerve stimuli had to be avoided. We therefore applied trains of nerve stimuli 
(200 Hz, 50 ms train duration) within the atrial refractory period. The antegrede Wancke- 
bach period was determined to assess a negative dromotropic effect. 
Results: PS in the SVC caused a significant increase in heart rate depending on the stim- 
ulation voltage as well as a significant increase of the antegrade Wenckebach cycle 
length. PS in the CS led to a voltage-dependent increase of the antegrade Wenckebach 
cycle length until AV-block I}1 occurred in 7 patients. The negative chronotropic and dro- 
motropic effects started/ceased immediately after the onset/end of nerve stimulation and 
were abolished by atropine. Patients reported on moderate chest discomfort during nerve 
stimulation. 
Conclusions: Transvascular electrical stimulation of human cardiac parasympathetic 
nerves can be achieved with conventional electrode catheters positioned in the SVC or 
CS. Using this novel stimulation technique, readily reversible negative chronotropic and 
dromotropic effects can be obtained. PS may be used for acute ventricular rate slowing 
during supraventricular tachycardias in patients with congestive heart failure or as a diag- 
nostic tool during electrophysiological studies. 
ABSTRACTS- Cardiac Arrhythmias  81A 
1041-105 First Evidence of Existence of a Localized Brainstem 
Center of Cardiovascular Control In Humans 
Vladimir Shusterrnan, Irmute Usiene, Benhur Avsin, Maksim Glukhovskoy, Peter J. 
Jannetta, University of Pittsburgh, Pittsburgh, Pennsylvania, Allegheny Genera/Hospital, 
Pittsburgh, Pennsylvania. 
Functional relations between human brainstem and cardiovascular system are complex, 
and existence of a localized brainstem center of cardiovascular control (BC) in humans 
has been debated. Here, we present the first evidence of existence of a localized BC in 
humans using mechanical stimulations of the surface of the brainstam at multiple sites. 
Methods. The ventrolataral surface of the medulia oblongata was exposed in 8pts (age: 
54±14y, 5male) undergoing neurosurgery, 3-7 equidistant sites were determined using 
metric paper, and at each site sequential mechanical stimulation of the brainstem surface 
was performed (frequency: 0.5-2Hz, duration:lmin) using a 2-ram metallic ball. Spatial 
changes in cardiac repolarization were examined using 32-1ead/192-site lectrocardio- 
graphic body surface potential maps. Blood pressure was monitored using intra-artedal 
line. Results. During the stimulation between the caudal rootlets of the 10th nerve (Fig- 
ure), the peak T-wave amplitude decreased (normalized difference:22%, range:6-50%, 
p=.025) and RR-intarvals became shorter (from 923+190 to 794±111ms, p=.063) com- 
pared to the recordings obtained before the stimulation. QT-intervat and the areas under 
the QRS and ST-segment did not change (p=.89,.78, and .40, respectively). Conclu- 
sions. Stimulation of a localized region of the ventrolateraI surface of the brainstem 
between the caudal rootlets of the 10th nerve elicits pronounced effects on cardiac 
rhythm and repolarization. 
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1041-106 The Effect of Spinal Cord Stimulation on Autonomic 
Activity and Cardiac Nitric Oxide Overflow 
Tamana Takahashi. Jeffrey E. Olgin, Jianyi Wu, Douglas P. Zipes, Krannert Institute of 
Cardiology, Indianapolis, Indiana. 
Background : Because spinal neurons influence intrinsic cardiac neurons, which in turn 
have their effects modulated by nitric oxide (NO) concentration, we measured the influ- 
ence of spinal cord stimulation (SCS) on autonomic modulation of cardiac properties and 
coronary sinus (CS) NO. 
Method : We measured the effect of SCS on spontaneous inus cycle length (SCL), atri- 
oventdcular (AV) nodal conduction time (AH interval during atrial pacing at CL 350- 
400msec. ) and CS NO concentration in 5 groups of normal, open chest dogs anesthe- 
tizod with alpha chloralose. 
Result : SCS with intact autonomics resulted in increase in both BCL and AH (all valuas 
in msec, n=18; BCL from 541 ±2 to 607±2; AH from 77±6 to 84±6, p<0.01). SCS with stel- 
late ganglion transection augmented the vagal-induced increase in BCL and AH (n=7; 
BCL from 683±3 to 707±2; AH from 103±7 to 112±7 , p<0.01) and blunted the sympa- 
thetic-induced shortening of BCL and AH (n=9; BCL from 331±1 to 396±1; AH from 52±5 
to 61±4 msec, p<0.01). Whereas SCS with vagal transection did not affect the sympa- 
thetic-induced shortening of BCL or AH (n=6; BCL from 344±4 to 345±4; AH from 70±7 
to 70±7) nor the vagal-induced increase in BCL and AH (n=9; BCL from 696±3 to 699±2; 
AH from 102±1 to 103±1). 
NO blood levels did not change significantly with SCS in any group. ( n=40; 121.8 ±31.3 
control and 117.2± 28.8 during SCS in nmol/min, p=0.58,). 
Conclusion; SCS augments vagal influences on the heart and can modulate (reduce) 
sympathetic influence on the heart by augmenting vagal activity and/or reducing sympa- 
thetic activity. 
